anti-DLL4 antibodies (Fabrus)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-DLL4 antibodies (Fabrus)
Drug Alias Namedelta-like ligand 4-targeted antibodies (Fabrus)
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionDelta-like protein 4 inhibitors
TargetsDelta-like protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFabrus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFabrus Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A